SAMPAOLESI, MAURILIO
 Distribuzione geografica
Continente #
NA - Nord America 4.323
EU - Europa 3.174
AS - Asia 2.155
Continente sconosciuto - Info sul continente non disponibili 8
SA - Sud America 8
OC - Oceania 7
AF - Africa 4
Totale 9.679
Nazione #
US - Stati Uniti d'America 4.305
CN - Cina 2.114
IE - Irlanda 1.003
UA - Ucraina 607
FI - Finlandia 436
DE - Germania 335
IT - Italia 232
SE - Svezia 196
GB - Regno Unito 171
BE - Belgio 92
FR - Francia 71
IN - India 23
CA - Canada 18
CZ - Repubblica Ceca 9
IR - Iran 9
EU - Europa 8
NL - Olanda 8
AU - Australia 6
RU - Federazione Russa 5
BR - Brasile 4
MU - Mauritius 4
CH - Svizzera 3
GR - Grecia 3
SG - Singapore 3
BD - Bangladesh 2
EC - Ecuador 2
VN - Vietnam 2
AR - Argentina 1
AT - Austria 1
CL - Cile 1
KZ - Kazakistan 1
LV - Lettonia 1
NZ - Nuova Zelanda 1
QA - Qatar 1
RO - Romania 1
Totale 9.679
Città #
Dublin 1.003
Chandler 938
Jacksonville 786
Nanjing 640
Ashburn 326
Nanchang 270
Princeton 215
Lawrence 209
Medford 203
Wilmington 198
Hebei 196
Shenyang 178
Ann Arbor 157
Jiaxing 157
Changsha 153
Boardman 128
Beijing 123
Helsinki 113
Hangzhou 103
Tianjin 100
Milan 76
Woodbridge 62
Shanghai 54
Pavia 53
Verona 51
Brussels 39
Herent 33
Norwalk 31
Fairfield 26
Los Angeles 26
Kunming 23
Seattle 22
Leuven 20
Pune 20
Washington 20
Des Moines 19
Guangzhou 16
Auburn Hills 15
Falls Church 14
Houston 13
Jinan 13
Toronto 13
New York 12
Redwood City 11
Zhengzhou 11
Dearborn 10
Ningbo 9
Brno 8
Taizhou 8
Lanzhou 7
Munich 7
Orange 7
San Francisco 5
Changchun 4
Ardabil 3
Borås 3
Buffalo 3
Fuzhou 3
Gunzenhausen 3
Hamburg 3
Lausanne 3
Redmond 3
Brisbane 2
Dong Ket 2
Ferrara di Monte Baldo 2
Helsingborg 2
Las Vegas 2
Miami 2
Quito 2
Rozzano 2
Shijiazhuang 2
Singapore 2
Sydney 2
Tappahannock 2
Varese 2
Walnut 2
Zanjan 2
Aberystwyth 1
Berlin 1
Bitonto 1
Bologna 1
Bondeno 1
Canberra 1
Cheyenne 1
Chicago 1
Ciampino 1
Collegno 1
Cornaredo 1
Dallas 1
Deventer 1
Doha 1
Doncaster 1
Duncan 1
Falkenstein 1
Groningen 1
Göttingen 1
Hamilton 1
Hefei 1
Indianapolis 1
Inzago 1
Totale 7.031
Nome #
Evaluation of energy expenditure in athletes practising horseback riding 106
ELECTROMAGNETIC FIELDS INFLUENCE GENE EXPRESION OF SAOS-2 CELL LINE 97
HGF-RELATED PROTEIN INDUCES MUSCLE HYPERTROPHY BOTH IN VITRO AND IN VIVO. 96
Characterization Of Cardiac Progenitors From Murine Dystrophic Heart. 96
Alpha sarcoglycan is required for FGF dependent myogenic progenitor cell proliferation in vitro and in vivo. 96
Magic-factor 1, a partial agonist of Met, induces muscle hypertrophy by protecting myogenic progenitors from apoptosis. 92
Analysis of the effect of high frequency vibrations on Saos-2 human osteoblasts in bone tissue engineering. 91
Improved adhesion and bone differentiation of Human Mesenchymal Stem Cells (hMSCs) and Human Dental Pulp Stem Cells (hDPSCs) on positively charged surfaces 90
In vitro adhesion and bone differentiation of Human Mesenchymal Stem Cells (hMSCs) and Human Dental Pulp Stem Cells (hDPSCs) on positively charged surfaces 90
Electromagnetic fields influence the gene expression of SAOS-2 cell line 88
GENE EXPRESSION PROFILE IN MAGIC-F1 MYOGENIC PROGENITORS 85
Adult Stem Cells And Tissue Engineering In Osteogenic Differentiation: Valutation Of The Binomial Bioreactor-Scaffold. 79
Cell therapy strategies and improvements for muscular dystrophy. 78
Valutation Of The Binomial Bioreactor-Scaffold In Osteogenic Differentiation Of Adult Stem Cells. 72
Tissue engineering of bone: biomaterials and electromagnetic influence on SAOS2 differentiation 72
A BIOCHEMICAL AND MOLECULAR STUDY OF STEM CELL ADHESION AND DIFFERENTIATIONON POSITIVELY CHARGED SURFACES 72
Magic Factor-1, a partial agonist of Met, induces muscle hypertrophy by protecting myogenic progenitors from apoptosis 70
Abnormal calcium homeostasis and cell damage in dystrophic myotubes 68
Tissue engineering of the bone: biomaterials and electromagnetic influence on SAOS-2 differentiation 68
Bisperoxovanadium, a phospho-tyrosine phosphatase inhibitor, reprograms myogenic cells to acquire a pluripotent, circulating phenotype. 66
Functional and morphological recovery of dystrophic muscles in mice treated with deacetylase inhibitors 66
Mesoangioblast stem cells ameliorate muscle function in dystrophic dogs. 65
Cardiac mesangioblasts are committed, self renewable progenitors, associated in small vessel of both adult normal and cardiomyopathic mouse ventricle 65
ROLE OF HUMAN SIALIDASES IN THE DIFFERENTIATION OF NORMAL AND PHATOLOGICAL SKELETAL MUSCLE TISSUE 65
Adult Stem Cells and Skeletal Muscle Regeneration 65
Impairment Of Cardiac Progenitor Diferentiation In The Murine Dystrophic Heart. 64
In Vivo Engrafment Of Cardiac Dystrophic Mesoangioblasts. 64
Hamster cardiomyocytes: a model of myocardial regeneration? 64
Intramuscular injection of human circulating AC133 positive cells ameliorates the function of scid/mdx dystrophic single muscle fibres 64
Altered functional differentiation of mesoangioblasts in a genetic myopathy. 64
Binding of sFRP-3 to EGF in the extra-cellular space affects proliferation, differentiation and morphogenetic events regulated by the two molecules. 63
Analysis of the molecular mechanism of sarcoglycanopathy: a new approach of gene therapy of limb-girdle and Duchenne-like dystrophy (TF 463/bi) 63
Gene signature of muscle hypertrophy 63
Cardiac dystrophic mesoangioblasts molecular characterization of in vitro and in vivo differentiation. 63
MmNEU3 sialidase over-expression in C2C12 myoblasts delays differentiation and induces hypertrophic myotube formation 62
Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors. 61
Cell Therapy of α-Sarcoglycan Null Dystrophic Mice Through Intra- Arterial Delivery of Mesoangioblasts 61
Cellular mechanisms and local progenitor activation to regulate skeletal muscle mass. 61
Role of miRNAs in Muscle Stem Cell Biology: Proliferation, Differentiation and Death. 61
Autologous transplantation of muscle-derived CD133+ stem cells in Duchenne muscle patients 61
Mesoangioblast Transplantation as a Cell Therapy for Muscular Dystrophy 60
New therapies for muscular dystrophy: cautious optimism. 60
The mesmiRizing complexity of microRNAs for striated muscle tissue engineering 60
Unconventional Players on the Striated Muscle Field: MicroRNAs, Signaling Pathways and Epigenetic Regulators 59
Stem cell therapy in muscular dystrophiesStem cell and small RNAs as tools for basic science and regenerative medicine 59
Brief Communication Arising 58
HGF-DERIVED RECOMBINANT PROTEIN SELECTIVELY ACTIVATES THE AKT PATHWAY AND INDUCES MUSCLE HYPERTROPHY 58
Met-Activating Genetically Improved Chimeric Factor-1 Promotes Angiogenesis and Hypertrophy in Adult Myogenesis 58
Cell therapy of muscular dystrophy by mesoangioblasts grafting in the dystrophic dogs 57
Stem Cell homing and regulation: new insights from muscular dystrophy 57
About Mesoangioblasts 57
Stem cell-niche and lysosomal cathepsins 57
Stem cells for the treatment of Muscular Dystrophy: more than a wishful thinking? 57
Magic Factor-1: a new engineered protein involved in muscular hypertrophy and regeneration 57
Skeletal muscle engineering: scaffolds and recombinant proteins 57
Complete repair of dystrophic skeletal muscle by mesoangioblasts with enhanced migration ability 56
Reversine-treated fibroblasts acquire myogenic competence in vitro and in regenerating skeletal muscle. 56
HGF-DERIVED RECOMBINANT PROTEIN M.A.G.I.C. F1: A NOVEL APPROACH TO INDUCE MUSCULAR HYPERTROPHY 56
Magic F1, a dimerized c-met binding domain, induces muscle hypertrophy by protecting from apoptosis myogenic progenitors 56
Phosphocaveolin-1 enforces tumor growth and chemoresistance in rhabdomyosarcoma 56
Skeletal myogenesis on highly orientated microfibrous polyesterurethane scaffolds. 56
HGF-derived recombinant protein M.A.G.I.C F1: a novel approach to induce muscular hypertrophy 55
Tuning multi/pluri-potent stem cell fate by electrospun poly(L-lactic acid)-calcium-deficient hydroxyapatite nanocomposite mats 55
Bedside to bench: a look at experimental research with a clinical trial checklist 55
Muscle hypertrophy and vascularization induction using recombinant proteins 55
Differentiation potential of human postnatal mesenchymal stem cells, mesoangioblasts, and multipotent adult progenitor cells reflected in their transcriptome and partially influenced by the culture conditions 55
Preclinical trial of mesoangioblast grafting in the Golden Retriever Muscular Dystrophy 54
Cardiac dystrphic mesoangioblasts: Molecular characterization of in vitro and in vivo differentiation 54
Alteration of cardiac progenitor cell potency in GRMD dogs 54
Pluripotent stem cell derivation and differentiation toward cardiac muscle: novel techniques and advances in patent literature. 54
Atrial natriuretic factor (ANF) and ANF receptor C gene expression and localization in the respiratory system: effects induced by hypoxia and hemodynamic overload. 54
Mouse, dog and human mesoangioblasts 53
Caffeine-induced Ca2+ signaling as an index of cardiac differentiation 53
HGF-DERIVED RECOMBINANT PROTEIN MAGIC F1: A NOVEL APPROACH TO INDUCE MUSCULAR HYPERTROPHY 53
Amniotic stem cells reprogramming for tissue regeneration in animal model prenatal myelomeningocele repair. 53
Synthetic sulfonyl-hydrazone-1 positively regulates cardiomyogenic microRNA expression and cardiomyocyte differentiation of induced pluripotent stem cells 53
Isolation and characterization of mesoangioblasts from mouse, dog, and human tissues. 52
Lentiviral vector gene transfer is limited by the proteasome at postentry steps in various types of stem cells. 52
Welcome to Cardiovascular Research in 2015 52
Fate choice of post-natal mesoderm progenitors: skeletal versus cardiac muscle plasticity. 52
Magic F1 hypertropic factor to enhance myogenesis on polyesterurethane scaffolds 52
Le cellule staminaliTra scienza, etica e usi terapeutici 51
Mouse and human mesoangioblasts: isolation and characterization from adult skeletal muscles. 51
Human postnatal dental pulp cells co-differentiate into osteoblasts and endotheliocytes: a pivotal synergy leading to adult bone tissue formation. 50
Extracellular HMGB1, a signal of tissue damage, induces mesoangioblast migration and proliferation. 50
Cardiac mesoangioblasts are committed, self-renewable progenitors, associated with small vessels of juvenile mouse ventricle. 50
Myogenic competences of fibroblasts in vitro and in vivo 50
Coordinated involvement of cathepsins S, D and cystatin C in the commitment of hematopoietic stem cells to dendritic cells 49
Recombinant proteins and PCL biomaterial to burst myogenesis in vitro 49
Novel hyperactive transposons for genetic modification of induced pluripotent and adult stem cells: a nonviral paradigm for coaxed differentiation 49
Long-term miR-669a therapy alleviates chronic dilated cardiomyopathy in dystrophic mice. 49
Molecular imaging of human embryonic stem cells stably expressing human PET reporter genes after zinc finger nuclease-mediated genome editing 49
Stretch-induced cell damage in sarcoglycan-deficient myotubes. 48
Electrospun degradable polyesterurethane membranes: potential scaffolds for skeletal muscle tissue engineering. 48
Stem Cell for the Treatment of Muscle Distrophy: More Than a Wishful Thinking? 47
Human cardiac mesoangioblasts isolated from hypertrophic cardiomyopathies are greatly reduced in proliferation and differentiation potency. 47
Terapia cellulare mesenchimale nella distrofia muscolare 47
Activin A Modulates CRIPTO-1/HNF4α+ Cells to Guide Cardiac Differentiation from Human Embryonic Stem Cells 47
In vitro and in vivo tissue engineering approaches in regenerative medicine 47
Human circulating AC133(+) stem cells restore dystrophin expression and ameliorate function in dystrophic skeletal muscle. 47
Totale 6.139
Categoria #
all - tutte 35.653
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.653


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.532 759 1.082 6 118 11 124 17 125 20 184 83 3
2020/20211.178 133 106 31 116 12 145 14 203 60 176 142 40
2021/2022860 19 6 19 9 14 13 17 53 57 15 135 503
2022/20232.805 358 174 32 226 280 275 0 167 1.170 14 73 36
2023/2024907 115 153 36 76 117 241 12 48 4 24 14 67
2024/20252 2 0 0 0 0 0 0 0 0 0 0 0
Totale 9.922